Nebraska Methodist Hospital

IMPROVING THE QUALITY OF LIFE THROUGH EXCELLENCE IN HEALTHCARE.

SOMEONE DIES FROM HEART DISEASE, STROKE OR ANOTHER CARDIOVASCULAR DISEASE EVERY 40 SECONDS IN THE UNITED STATES, ACCORDING TO THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR DISEASE, AS THE UNDERLYING CAUSE OF DEATH, ACCOUNTS FOR NEARLY 874,000 DEATHS IN THE U.S WHICH IS ABOUT ONE OUT OF EVERY 3.METHODIST HOSPITAL HAS BEEN A LEADER IN THE CARE AND TREATMENT OF THOSE WHO COME TO US IN OUR EMERGENCY DEPARTMENT OR ARE DIAGNOSED WITH CARDIOVASCULAR DISEASE. WE HAVE LONG BEEN AT THE FOREFRONT IN CARING FOR THESE PATIENTS AND ARE ALWAYS EXPLORING WAYS TO ENHANCE THEIR TREATMENT AND LIFESTYLE.METHODIST HOSPITAL'S COMMITMENT AND SUCCESS IN IMPLEMENTING AN EXCEPTIONAL STANDARD OF CARE FOR CARDIAC PATIENTS HAS BEEN RECOGNIZED BY THE AMERICAN HEART ASSOCIATION AND THE JOINT COMMISSION.2022 ACCOMPLISHMENTS IN THE CARDIOLOGY AREA INCLUDED THE FOLLOWING:CARDIOTHORACIC SURGEON DR. HELENMARI MERRITT-GENORE WAS THE FIRST SURGEON IN NEBRASKA TO USE ROBOTIC SURGICAL EQUIPMENT TO REPAIR A MITRAL VALVE.METHODIST HOSPITAL RECEIVED A THREE-STAR RATING FROM THE SOCIETY OF THORACIC SURGEONS (STS) FOR ITS PATIENT CARE AND OUTCOMES IN ISOLATED CORONARY ARTERY BYPASS GRAFTING (CABG) PROCEDURES. THE THREE-STAR RATING, WHICH DENOTES THE HIGHEST CATEGORY OF QUALITY, PLACES THE HOSPITAL AMONG THE ELITE FOR HEART BYPASS SURGERY IN THE UNITED STATES AND CANADA. THE CARDIOLOGY TEAM AT METHODIST HOSPITAL MET SEVERAL WATCHMAN PROCEDURE MILESTONES IN 2022, PERFORMING THEIR 500TH, 700TH AND 800TH PROCEDURES. THE HOSPITAL WAS A REGIONAL VOLUME LEADER IN 2022. THE VASCULAR TEAM AT METHODIST TREATED THEIR 100TH PATIENT WITH HYBRID AF THERAPY (CONVERGENT). METHODIST CONTINUES TO BE NAMED AS ONE OF THE TOP 5 OF 225 PROGRAMS NATIONWIDE THREE YEARS RUNNING.METHODIST WAS THE TOP ENROLLING SITE GLOBALLY WITH NINE OF THE FIRST 51 PATIENTS IN THE HI-PEITHO TRIAL, WHICH IS A RESEARCH STUDY FOCUSED ON THE TREATMENT OF PULMONARY EMBOLISMS. METHODIST HOSPITAL EARNED THE MISSION: LIFELINE ST ELEVATION MYOCARDIAL INFRACTIONS (STEMI) RECEIVING SILVER PLUS AWARD FROM THE AMERICAN HEART ASSOCIATION.

METHODIST HOSPITAL RECEIVED A FIVE-STAR OVERALL HOSPITAL QUALITY STAR RATING FROM THE CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS). METHODIST HOSPITAL WAS ONE OF SEVEN HOSPITALS IN NEBRASKA TO EARN THE DESIGNATION. A TOTAL OF 429 HOSPITALS ACROSS THE COUNTRY OBTAINED FIVE STARS.METHODIST HOSPITAL EARNED THE MISSION: LIFELINE STEMI RECEIVING SILVER PLUS AWARD FROM THE AMERICAN HEART ASSOCIATION.

AT NEBRASKA METHODIST HOSPITAL, WE UNITE ALL OF OUR RESOURCES TO JOIN OUR PATIENTS IN THEIR FIGHT AGAINST CANCER IN ITS TOTALITY. OUR UNIQUE MULTIDISCIPLINARY APPROACH IS ONE OF METHODIST'S GREATEST STRENGTHS. WORKING TOGETHER WITH THE PATIENT ON THE TEAM, WE FOCUS A RARE LEVEL OF COMBINED EXPERTISE TO EXPAND TREATMENT OPTIONS, IMPROVE OUTCOMES AND PROVIDE COMFORT AND HOPE.WE OFFER A FULL LINE OF CANCER SERVICES AT MECC INCLUDING: BREAST CARE CENTER, CHEMOTHERAPY, CLINICAL TRIALS, GYNECOLOGIC ONCOLOGY, HEAD AND NECK ONCOLOGY, LUNG/THORACIC ONCOLOGY, MULTIDISCIPLINARY TEAM APPROACH, NUTRITION SERVICES, OCCUPATIONAL AND SPEECH THERAPY, PHYSICAL WELLNESS PROGRAMS, PSYCHO-ONCOLOGY SERVICES, RADIATION ONCOLOGY, REHABILITATION, SOCIAL WORK, STEM CELL TRANSPLANTS, SUPPORT SERVICES, SURGICAL ONCOLOGY AND TUMOR REGISTRY.CANCER SCREENINGS HAVE RESUMED AFTER A BRIEF PAUSE DUE TO COVID-19. OUR MOBILE MAMMOGRAPHY COACH WAS ON THE ROAD A GREAT DEAL IN 2022, AS WE PREFORMED 2,492 MAMMOGRAM SCREENINGS 434 WERE BASELINE MEANING A FIRST-TIME SCREENING. OF THOSE NEARLY 2,500 SCREENINGS, 45 WOMEN WERE RECOMMENDED FOR BIOPSIES AND 15 POSITIVE CANCERS WERE DETECTED. FREE HEAD AND NECK SCREENINGS ALSO RESUMED IN OMAHA, COUNCIL BLUFFS AND FREMONT. ANOTHER SCREENING INITIATIVE IN WHICH METHODIST CONTINUES TO BE A LEADER IS OUR LUNG CANCER PROGRAM. WE WERE ONE OF THE FIRST IN THE REGION TO OFFER A LOWDOSE CT SCREENING PROGRAM, ALLOWING US TO CATCH CANCER AT A MUCH EARLIER STAGE. A RECENTLY INTEGRATED SOFTWARE SYSTEM/S FOR OUR LUNG CLINICS HAS HELPED BOLSTER OUR EFFORTS RELATED TO INCIDENTAL LUNG NODULES POSSIBLY CANCEROUS MASSES IDENTIFIED INCIDENTALLY DURING UNRELATED PROCEDURES BY STREAMLINING NAVIGATION, DATA COLLECTION, ANALYTICS AND DECISION-MAKING.METHODIST HOSPITAL BECAME THE FIRST IN NEBRASKA AND THE REGION TO ACQUIRE THE ION BY INTUITIVE A ROBOTIC-ASSISTED SURGICAL SYSTEM FOR LUNG BIOPSIES. THE NEW TECHNOLOGY HELPS PHYSICIANS BETTER ACCESS LUNG NODULES TO DETECT AND OBTAIN TISSUE SAMPLES. INSTEAD OF TAKING A WAIT-AND-SEE APPROACH IN SOME CASES, PHYSICIANS USING THE ION TECHNOLOGY WILL BENEFIT FROM DIAGNOSTIC ANSWERS AND BE ABLE TO JUMP-START THE PATH TO TREATMENT IF WARRANTED.THE AMERICAN CANCER SOCIETY RENEWED A GRANT TO METHODIST HOSPITAL ALLOWING IT TO ADDRESS THE UNMET TRANSPORTATION NEEDS OF CANCER PATIENTS IN THE REGION, PARTICULARLY VULNERABLE POPULATIONS WHO ARE EXPERIENCING AN UNEQUAL BURDEN OF CANCER. THE GRANTS ARE AVAILABLE TO HEALTH SYSTEMS, TREATMENT CENTERS AND COMMUNITY ORGANIZATIONS IN SELECT COMMUNITIES THROUGH AN APPLICATION PROCESS. THEY FOCUS ON ADDRESSING THE UNMET TRANSPORTATION NEEDS OF CANCER PATIENTS, PARTICULARLY VULNERABLE POPULATIONS EXPERIENCING AN UNEQUAL BURDEN OF CANCER. OUR WORK TO PREVENT HPV-RELATED CANCERS IS ANOTHER AREA IN WHICH METHODIST IS LEADING THE WAY THROUGH EDUCATION AND RAISING AWARENESS AMONG PATIENTS AND PROVIDERS. WE ARE PART OF AN EXTENDED GRANT FROM THE AMERICAN CANCER SOCIETY'S HOSPITAL SYSTEM CAPACITY BUILDING INITIATIVE AS A COMMUNITIES OF PRACTICE LOCATION. THE GRANT HAS ALLOWED US TO FOCUS OUR EFFORTS ON CONSUMER COMMUNICATIONS, HPV RELATED PODCASTS FOR MEDICAL PROFESSIONALS AND ENGAGING OUR STAFF ON THE IMPORTANCE OF THE HPV VACCINE AS A CANCER-FIGHTING TOOL. MECC HAS BEEN DESIGNATED AS A CARE CONTINUUM CENTER OF EXCELLENCE BY GO2 FOUNDATION FOR LUNG CANCER (GO2 FOUNDATION). METHODIST HOSPITAL JOINS MORE THAN 60 OTHER COMMUNITY HOSPITALS AND WAS THE FIRST IN NEBRASKA TO BE HONORED WITH THE DESIGNATION, WHICH RECOGNIZES COMMITMENT TO IMPROVING OUTCOMES FOR THOSE DIAGNOSED WITH LUNG CANCER BY PROVIDING PATIENT-FOCUSED AND COORDINATED MULTIDISCIPLINARY CARE. MECC WAS GRANTED A THREE-YEAR ACCREDITATION DESIGNATION BY THE NATIONAL ACCREDITATION PROGRAM FOR BREAST CENTERS (NAPBC), A PROGRAM ADMINISTERED BY THE AMERICAN COLLEGE OF SURGEONS. METHODIST WAS THE FIRST IN NEBRASKA TO BE ACCREDITED IN 2009 AND HAS EARNED CONSECUTIVE RE-ACCREDITATIONS IN 2012, 2015, 2018 AND 2022.MECC IS ALSO NATIONALLY RECOGNIZED AS AN APPROVED NPF PANCREATIC CANCER CENTER BY THE NATIONAL PANCREAS FOUNDATION. MECC IS THE ONLY NPF CENTER SERVING PATIENTS IN NEBRASKA AND IOWA, AND IT'S ONE OF FEWER THAN 70 NPF CENTERS NATIONWIDE. WE ARE ALSO ACCREDITED BY THE FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY (FACT) AT THE UNIVERSITY OF NEBRASKA MEDICAL CENTER. IN ADDITION TO PROVIDING THE STANDARD TREATMENTS, THE PHYSICIANS AT METHODIST HOSPITAL AND MECC HAVE CONSISTENTLY DEMONSTRATED ACTIVE PARTICIPATION IN CANCER PREVENTION AND TREATMENT TRIALS APPROVED BY THE NATIONAL CANCER INSTITUTE (NCI). EVERY CANCER PATIENT TREATED HERE IS EVALUATED FOR ELIGIBILITY IN NCI-APPROVED TRIALS, AND TRIAL PARTICIPATION IS ENTIRELY VOLUNTARY. ONLY ABOUT 3-5% PERCENT OF ADULT CANCER PATIENTS NATIONWIDE PARTICIPATE IN CLINICAL TRIALS, ACCORDING TO THE NCI. MECC EXCEEDS THAT ON A REGULAR BASIS. OUR CLINICAL TRIALS ARE OVERSEEN BY A HIGHLY TRAINED, MULTIDISCIPLINARY TEAM OF CANCER SPECIALISTS IN COLLABORATION WITH THE PATIENT'S PRIMARY CARE PROVIDER.

THROUGHOUT OUR CAMPUSES, METHODIST IS FOCUSING ON PROVIDING SPECIALIZED CARE FOR WOMEN. WITH THE ONLY MEDICAL CAMPUS IN THE REGION DEDICATED TO WOMEN'S HEALTH, METHODIST IS A LEADER IN PROVIDING CARE TO WOMEN FROM THE TEENAGE YEARS THROUGHOUT THEIR LIVES. METHODIST IS THE LONG-TIME METRO AREA LEADER IN BIRTH SERVICES, DELIVERING A MORE COMPREHENSIVE ARRAY OF FAMILY PLANNING OPTIONS - AND MORE BABIES - THAN ANY OTHER HOSPITAL IN THE REGION. IN 2022, METHODIST WOMEN'S HOSPITAL ECLIPSED 5,000 BIRTHS FOR THE FIRST TIME IN FIVE YEARS. MANY OF THOSE BABIES OFTEN NEED A HIGHER LEVEL OF CARE AND THE METHODIST WOMEN'S HOSPITAL NICU HAS BEEN PROVIDING SUCH CARE SINCE OPENING IN 2010. THE NICU QUICKLY REACHED CAPACITY AND IN 2017 AN EXPANSION PROJECT WAS COMPLETED. IN 2021, METHODIST WOMEN'S HOSPITAL RECEIVED APPROVAL FROM THE METHODIST FOUNDATION BOARD OF DIRECTORS TO MOVE FORWARD WITH A CAPITAL CAMPAIGN TO AGAIN EXPAND THE NICU TO THE WEST, RESULTING IN 10 TO 12 ADDITIONAL NICU ROOMS. THIS EXPANSION WILL POSITIVELY IMPACT NICU AND ADULT BED CAPACITY AND WILL BE COMPLETED LATE 2023/EARLY 2024. STAFFED BY A HIGHLY SPECIALIZED NEONATAL TEAM, THE NICU IS DESIGNATED A LEVEL III UNIT - THE HIGHEST LEVEL OF CARE IN WEST OMAHA. METHODIST IS HOME TO THE LARGEST OB/GYN PRACTICE IN THE REGION, AS WELL AS ONE OF THE LEADING MATERNAL-FETAL MEDICINE CLINICS SERVING OMAHA AND BEYOND. IN 2022, METHODIST WOMEN'S HOSPITAL OPENED A LOW-INTERVENTION BIRTH SUITE FOR PATIENTS DESIRING A MORE NATURAL, UNMEDICATED BIRTH EXPERIENCE WITHIN THE SAFETY NET OF THE HOSPITAL.THE MATERNAL-FETAL MEDICINE TEAM CONTINUES ITS OUTREACH SERVICES TO PATIENTS IN WESTERN NEBRASKA AND WESTERN IOWA, EXTENDING A HIGH LEVEL OF CARE CLOSER TO HOME TO THOSE FACING A HIGHER RISK PREGNANCY. U.S. NEWS & WORLD REPORT NAMED ONLY ONE HOSPITAL IN NEBRASKA METHODIST WOMEN'S HOSPITAL AS A 2022-2023 HIGH PERFORMING HOSPITAL FOR MATERNITY CARE RANKINGS. THIS IS THE HIGHEST AWARD A HOSPITAL CAN EARN FOR U.S. NEWS' BEST HOSPITALS FOR MATERNITY CARE. METHODIST WOMEN'S HOSPITAL EARNED A HIGH PERFORMING DESIGNATION IN RECOGNITION OF MATERNITY CARE AS MEASURED BY FACTORS SUCH AS NEWBORN COMPLICATION RATES.